by Jim Thompson | Mar 10, 2014 | Antiretrovirals, CROI, CROI 2014, Cure, Pediatrics |
CROI 2014: Mississippi Baby Update The Mississippi Baby born in 2010 at high risk of transmission from her mother was started on a triple cocktail immediately after birth, and continued on the medicines as an infected child anticipating that she would stay on those...
by Jim Thompson | Mar 10, 2014 | CROI, CROI 2014, Women |
CROI 2014: Women’s Issues Data is discussed from work the single poster presentation at CROI explicitly focused on HIV stigma. The study looked at rural Kenya researching HIV stigma and its social impact on pregnant women and resulted in a link between...
by Jim Thompson | Mar 10, 2014 | Aging, CROI, CROI 2014 |
CROI 2014: Aging An expert panel discussing the importance of the role that HIV plays with depression, cardiovascular disease, osteoporosis, and cancer risk factors that affect individuals living and aging with HIV. Presented at CROI this year was data demonstrating...
by Jim Thompson | Mar 10, 2014 | CROI, CROI 2014, Microbicides, Prevention |
CROI 2014: Microbicides Two prominent members from AVAC’s Global Advocacy for HIV Prevention team expound on the paradigm shift that is occurring around the nomenclature for ‘long lasting’ treatments. New options for HIV prevention exist and are in...
by Jim Thompson | Mar 10, 2014 | CROI, CROI 2014, Cure |
CROI 2014: The Cure A discussion on elements surrounding HIV Cure research including viral persistence and its impact on HIV cure research, with discussion that viral persistence is proving to be more complex than originally expected by early researcher leading to the...
by Jim Thompson | Mar 10, 2014 | CROI, CROI 2014, Prevention |
CROI 2014: The Science of PrEP There is to date one approved oral Pre-Exposure Prophylaxis antiretroviral medication that can prevent HIV infection if taken regularly. Alternatives in development presented at CROI include topical agents, injectable agents, and...
